We can't find the internet
Attempting to reconnect
29722.1 IP-LS
29722.1 IP-LS
Zusammenfassung
Molecular target validation and profiling of a novel class of anti-triple-negative breast cancer (TNBC) small-molecule Wnt pathway inhibitors.
Weitere Texte
Abstract
This project aims to validate and provide necessary data on the molecular target(-s) of our novel anti-Wnt signaling scaffold demonstrating excellent anti-cancer properties and safety profile. These data are essential for their acceptance and further structure-driven development in pharma companies.
Beteiligte
Vladimir Katanaev
Kontaktperson
vladimir.katanaev@unige.ch
Université de Genève Vladimir Katanaev Rue Michel Servet 1 1211 Genève GE CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2018-09-30
- Enddatum
- 2021-01-31
- Bewilligte Gesamtkosten
- CHF 265885.49
- Sektion
- 60 Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T410 Pharmaceuticals and related technologies 100.0%